GSK Sp ADR (GSK)

$37.86 0.01 (0.03%)

20:00 EDT GSK Stock Quote Delayed 30 Minutes

3 Pharma Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 11, 2023

Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.

If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

Volume:

Previous Close $38.74

Market Cap 167.14B

PE Ratio 60.87

EPS 0.622

Volume (Avg. Vol.) 5.29M

Day's Range $37.68 - $38.77

52-Week Range $31.37 - $44.37

Dividend & Yield $1.55 (4.11%)

GSK Stock Predictions, Articles, and GSK Sp ADR News

7 Healthcare Stocks to Make You the Millionaire Next Door

By Larry Ramer, InvestorPlace Contributor Jun 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

3 Personalized Medicine Stocks to Buy for Long-Time Returns

By John Blankenhorn, InvestorPlace Contributor May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

GSK Stock: A Value Trap or a Hidden Gem?

By Samuel O'Brient, InvestorPlace Reporter Apr 27, 2023

GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.

Why Is Bellus Health (BLU) Stock Up 98% Today?

By William White, InvestorPlace Writer Apr 18, 2023

Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).

Why Is Scynexis (SCYX) Stock Up 69% Today?

By William White, InvestorPlace Writer Mar 30, 2023

Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.

3 Pharma Stocks That Could Benefit from Global Healthcare Trends

By Larry Ramer, InvestorPlace Contributor Mar 17, 2023

The best pharma stocks to buy are those that are poised to be greatly boosted by drugs that are well-positioned to become blockbusters.

3 High Dividend Stocks With Attractive Total Return Potential

By Bob Ciura, Sure Dividend Mar 10, 2023

In the current economic environment, it is crucial for investors to prioritize quality, reliable dividend stocks and high total returns.

7 Drug Stocks That Will Soar in 2023

By Larry Ramer, InvestorPlace Contributor Dec 22, 2022

These drug stocks to buy look poised to generate huge profits for investors., both in 2023 and in subsequent years.

7 Quality Stocks Selling at a Discount as Q4 Kicks Off

By Larry Ramer, InvestorPlace Contributor Oct 19, 2022

Stocks may have just entered a bull market, so bullish investors should look for quality stocks selling at a discount to buy before a rally.

This Is the Best Time to Buy These 7 Long-Term Dividend Stocks

By Chris Lau, InvestorPlace Contributor Oct 3, 2022

Investors want long-term dividend stocks to buy to shield against the negative headwinds from higher interest rates.

7 Stocks to Buy That Can Soar in Good Times or in Bad

By Larry Ramer, InvestorPlace Contributor Sep 22, 2022

Investors looking for growth stocks to buy that are largely immune from broader economic woes have come to the right place.

GSK, PFE, SNY Stocks Fall on Zantac Litigation

By David Moadel, InvestorPlace Contributor Aug 11, 2022

You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.

7 Dividend Stocks to Buy on the Dip

By Larry Ramer, InvestorPlace Contributor Jul 27, 2022

The stock market is volatile and bottoming, making it a good time to buy dividend stocks on the dip. Here are seven worth your consideration.

3 Biotech Stocks to Buy on the Dip

By Larry Ramer, InvestorPlace Contributor Jul 21, 2022

Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel, InvestorPlace Contributor Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

7 Stocks to Buy if Covid-19 Becomes Endemic

By Josh Enomoto, InvestorPlace Contributor Dec 20, 2021

Watching the developments of the Covid-19 crisis, it could become endemic. Here’s what that means for certain stocks to buy.

VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.

By Samuel O'Brient, InvestorPlace Reporter Nov 30, 2021

Vir Biotechnology has a Covid-19 treatment that its CEO says will do well against new variants. Amid uncertainty, VIR stock is climbing.

The 7 Best Stocks to Buy for September

By Muslim Farooque, InvestorPlace Contributor Aug 30, 2021

From vaccines to video games, these stocks to buy have the most attractive long-term bull cases in their respective industries.

7 High-Yield Dividend Stocks to Get You Through Market Volatility

By Josh Enomoto, InvestorPlace Contributor Aug 12, 2021

With the pandemic causing much uncertainty in the economy, these high-yielding dividend stocks to buy could offer some reassurances.

ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher

By William White, InvestorPlace Writer Jul 2, 2021

Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK).

GSK Sp ADR (GSK)

3 Pharma Stocks to Sell in August Before They Crash and Burn

If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GSK Sp ADR (GSK)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GSK Stock Predictions, Articles, and GSK Sp ADR News

Subscriber Sign in